Читать книгу Essential Endocrinology and Diabetes - Richard I. G. Holt - Страница 71
Second messenger pathways Cyclic adenosine monophosphate
ОглавлениеActivation of membrane‐bound adenylate cyclase catalyzes the conversion of ATP to the second messenger cAMP (Figure 3.11). cAMP interacts with protein kinase A (PKA), which unmasks its catalytic site to allow phosphorylation of serine and threonine residues on a transcription factor called cAMP response element‐binding protein (CREB) (Figure 3.15). CREB then translocates to the nucleus where it binds to a short palindromic sequence in the regulatory regions of cAMP‐regulated genes. This signalling pathway controls major metabolic pathways, including those for lipolysis, glycogenolysis and steroidogenesis.
The cAMP response is terminated by a large family of phosphodiesterases, which can be activated by a variety of systems, including phosphorylation by PKA, in effect providing a negative feedback loop. Phosphodiesterases rapidly hydrolyze cAMP to the inactive 5′‐AMP. In addition, activated PKA can phosphorylate serine and threonine residues of the GPCR to cause receptor desensitization.
Table 3.1 Use of different G‐protein α‐subunits by various hormone signalling pathways
Hormone | Dominant G‐protein α‐subunit(s) |
---|---|
Thyrotrophin‐releasing hormone (TRH) | Gqα |
Corticotrophin‐releasing hormone (CRH) | Gsα |
Gonadotrophin‐releasing hormone (GnRH) | Gqα |
Somatostatin (SS) | Giα/Gqα |
Thyroid‐stimulating hormone (TSH) | Gsα/Gqα |
Luteinizing hormone (LH)/human chorionic gonadotrophin (hCG) | Gsα/Gqα |
Follicle‐stimulating hormone (FSH) | Gsα/Gqα |
Adrenocorticotrophic hormone (ACTH) | Gsα |
Oxytocin | Gqα |
Vasopressin | Gsα/Gqα |
Catecholamines (β‐adrenergic) | Gsα |
Angiotensin II (AII) | Giα/Gqα |
Glucagon | Gsα |
Calcium | Gqα/Giα |
Calcitonin | Gsα/Giα/Gqα |
Parathyroid hormone (PTH)/PTH‐related peptide (PTHrP) | Gsα/Gqα |
Prostaglandin E2 | Gsα |
For signalling by SS, vasopressin, AII, calcitonin and PTH/PTHrP, different receptor subtypes, potentially in different tissues, determine α‐subunit specificity. This provides opportunities for selective antagonist therapies.